[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
From the MMWR
November 1999

Recommendations for the Use of Lyme Disease Vaccine

Arch Dermatol. 1999;135(11):1425-1426. doi:10-1001/pubs.Arch Dermatol.-ISSN-0003-987x-135-11-dmm1199

LYME DISEASE vaccine does not protect all recipients against infection with B. burgdorferi and offers no protection against other tickborne diseases. Vaccinated persons should continue to practice personal protective measures against ticks and should seek early diagnosis and treatment of suspected tickborne infections. Because Lyme disease is not transmitted person-to-person, use of the vaccine will not reduce risk among unvaccinated persons. Decisions regarding the use of vaccine should be based on individual assessment of the risk for exposure to infected ticks and on careful consideration of the relative risks and benefits of vaccination compared with other protective measures, including early diagnosis and treatment of Lyme disease. The risk for Lyme disease is focally distributed in the United States. Detailed information regarding the distribution of Lyme disease risk within specific areas is best obtained from state and local public health authorities.